A Look at Smart Packaging for Compliance
Compliance packaging utilizing electronics has been often presented as a viable means of encouraging patients to follow drug regimens. A new report from Applied Data Research assesses this market and its future.
"Although electronic means of monitoring patient compliance have been in the market for the last decade, they have not gained widespread acceptance due to a number of factors including cost, size, and the fact that until recently they did not integrate well in the medication-taking process," reports the firm in a press release. "In the past few years, technology in the form of so-called smart packaging has gained interest as a means to achieve a higher level of data integrity and patient compliance with drug protocols."
Applied Data Research notes that "several market participants are focusing on a handful of high-profile, high-stakes segments that typically include cardiovascular and neurological drugs, drugs for treating metabolic diseases, and drugs with a significant risk associated with overdosing such as opiates prescribed for pain management."
More information is also available at www.applieddata.org. Applied Data Research is a healthcare technology consulting firm focused on market strategies, product commercialization, venture development, and market research.